Not the End of the Physician-Scientist

In 1984 Gordon N. Gill, professor of medicine at the University of California at San Diego, published an essay entitled “The End of the Physician Scientist?” He described how from the mid- 1960s to the early 1980s the biomedical research enterprise in the United States passed largely out of the realm of clinical investigators and into that of Ph.D. scientists working at the molecular leveL He also noted that in the United Kingdom and Europe the split between basic science and clini

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

In 1984 Gordon N. Gill, professor of medicine at the University of California at San Diego, published an essay entitled “The End of the Physician Scientist?” He described how from the mid- 1960s to the early 1980s the biomedical research enterprise in the United States passed largely out of the realm of clinical investigators and into that of Ph.D. scientists working at the molecular leveL He also noted that in the United Kingdom and Europe the split between basic science and clinical medicine had been completed by the early 1970s. The clinician-scientist had become the “clinician-applier of basic science.” (American Scholar, vol. 53, 1984, p. 360.) “Like it or not,” Gill concluded, “the separation of physicians and scientists is well advanced.. . . Partial attention to either science or medicine is no longer enough” (p. 368).

Gill, while astutely describing a genuine and broad historic shift, I think too quickly ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Eugene Garfield

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo